Aging And Digital Trends Will Advance Insulin Delivery Solutions
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
01 Jun 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
US$25.00
42.5% undervalued intrinsic discount20 Aug
US$14.38
1Y
2.7%7D
5.0%